Insider · CIK 0001741284
Richard Gaynor
Files at ALKS (Alkermes plc.), ZLAB (Zai Lab Ltd). First filing Mar 6, 2025, latest Mar 19, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZLAB: Zai Lab Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | Zai Lab Ltd | $33k 1,731 shares | +3% | +17% from low-56% from high | |
| 19Weak | Zai Lab Ltd | $88k 2,500 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | ZLAB Zai Lab Ltd | POpen-market purchase American Depositary Shares10b5-1 | +1,731 | $18.91 | $33k | 56,630 | Mar 19, 2026 |
| Jun 18, 2025 | ZLAB Zai Lab Ltd | AGrant or award American Depositary Shares | +10,831 | $0.00 | $0 | 54,899 | Jun 23, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +8,013 | - | - | 33,008 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,924 | $30.61 | $59k | 31,084 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -8,013 | - | - | 0 | Jun 2, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +13,474 | $0.00 | $0 | 13,474 | May 23, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +6,142 | $0.00 | $0 | 6,142 | May 23, 2025 |
| Mar 5, 2025 | ZLAB Zai Lab Ltd | SOpen-market sale American Depositary Shares10b5-1 | -2,500 | $35.07 | $88k | 44,068 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.